Effect of glucosamine in the treatment of psoriasis

Phase 3

• Conditions: Psoriasis vulgaris.; Psoriasis vulgaris; L40.0

• Registration Number: IRCT20200817048439N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients of older than 18 years
Patients with plaque psoriasis

Exclusion Criteria

Use of any topical or oral medication affecting the course of the disease in the last three months
Irregular attendance for visits
Occurrence of any complications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psoriasis area and severity index (PASI). Timepoint: Every two weeks. Method of measurement: Calculated by the severity index and psoriasis area formula.